Cagrilintide
For Research Use Only · Not for Human Consumption
Weight lossMetabolic
Cagrilintide is a synthetic analogue of the pancreatic hormone amylin, engineered for extended half-life through fatty-acid acylation. It is used in co-administration research with incretin agonists to investigate dual amylin/GLP-1 receptor pharmacology. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •Long-acting amylin analogue — slows gastric emptying and lowers food intake.
- •Combined with semaglutide (CagriSema) achieved ~13.7% weight loss in NEJM data.
- •Synergistic appetite suppression with GLP-1 receptor agonists in preclinical models.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificateOut of stock
—per vial